A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...
Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of ...
A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...
Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...
Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
A study reveals tthat a ransplant protocol designed by Columbia researchers diminishes rejection in xenotransplantation.
These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.
These studies represent promising new treatment options for chronic and progressive kidney diseases, offering renewed hope to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback